Skip to content

The analysis of single-port laparoscopic lateral mesh suspension with improved micro puncture for pelvic organ prolapse

The analysis of single-port laparoscopic lateral mesh suspension with improved micro puncture for pelvic organ prolapse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118158
Enrollment
Unknown
Registered
2026-02-02
Start date
2022-08-22
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Experimental group :single-port laparoscopic lateral mesh suspension with improved micro puncture
Control group:Laparoscopic lateral suspension

Sponsors

Chengdu First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Pelvic Organ Prolapse Quantification (POP-Q) stage II or above who voluntarily opt for surgical treatment; 2.Patients who have not undergone previous surgery for pelvic organ prolapse or major pelvic surgery; 3.Patients with no significant surgical contraindications who can tolerate anesthesia and surgery; 4.Patients and their families have been informed about the study and agree to participate; 5.Patients who are able to comply with medical advice and avoid immediate strenuous physical activities postoperatively that may affect recovery.

Exclusion criteria

Exclusion criteria: 1.Patients with severe comorbidities; 2.Patients who had received hormone replacement therapy prior to enrollment; 3.Patients with concomitant severe pathologies of the uterus or ovaries, etc.; 4.Patients who underwent additional concurrent surgical procedures; 5.Patients in poor general condition unable to tolerate general anesthesia and surgery; 6.Patients unable to cooperate with or complete the follow-up.

Design outcomes

Primary

MeasureTime frame
The stage of Pelvic Organ Prolapse Quantification System;

Secondary

MeasureTime frame
The score of Pelvic Floor Distress Inventory-20;The score of Pelvic Floor Impact Questionnaire-7;the score of Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire;

Countries

China

Contacts

Public ContactLi Min

Chengdu First People's Hospital

58311040@qq.com+86 139 8072 5300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026